United States Preventive Healthcare Market is expected to reach US$ 1,161.65 Billion by 2032 | Top key players - Pfizer Inc., AstraZeneca, GSK plc.

Market Size and Forecast:

The Global Preventive Healthcare Market Size reached US$ 388.17 billion in 2024 and is expected to reach US$ 1,161.65 billion by 2032, growing at a CAGR of 14.1% during the forecast period 2025-2032.

The Preventive Healthcare Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/preventive-healthcare-market?sz

The Preventive Healthcare Market encompasses services, products, and technologies aimed at disease prevention, early detection, and health risk management. It includes wellness programs, diagnostic tests, vaccines, screenings, and health monitoring tools designed to reduce the incidence of chronic and acute illnesses. The market focuses on proactive healthcare, improving quality of life, and lowering long-term medical costs through prevention and early intervention.

Industry Recent Developments:

United States:

✅ July 2025: CVS Health expanded preventive care programs with AI-driven health monitoring kiosks in retail locations, providing instant health assessments and personalized recommendations, leading to improved preventive care adherence.

✅ August 2025: Mayo Clinic introduced predictive analytics tools for preventive screenings and wellness management to identify high-risk patients and suggest tailored checkups, enhancing early intervention outcomes.

✅ September 2025: UnitedHealth Group launched an AI-powered preventive health platform for chronic disease risk assessment that analyzes patient data and recommends personalized lifestyle interventions, showing early success in reducing hospitalizations.

Japan:

✅ July 2025: Japan Agency for Medical Research and Development (AMED) supported ongoing grants for innovative medical products focused on disease prevention, alongside enhanced consultation services for pediatric medicine development by PMDA.

✅ August-September 2025: The Japanese mHealth market surged due to aging population needs and technological advances, with increased adoption of remote patient monitoring, chronic disease management, and mental wellness platforms integrating with traditional healthcare.

✅ October 2025: The Japan Preventive Healthcare Technologies and Services Market projected strong growth driven by demographic changes, digital health advances such as wearables and telehealth, and government initiatives promoting early disease detection and wellness management. Market size estimated at USD 12.8 billion in 2025, growing at a CAGR of 9.8% till 2032.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/preventive-healthcare-market?sz

Major Key Players:

Pfizer Inc.
AstraZeneca
GSK plc.
Sanofi
Merck & Co., Inc.
Meridian Bioscience
Exact Sciences Corporation.
GRAIL, Inc.
Myriad Genetics, Inc.
Apple Inc.
SAMSUNG
Fitbit
Bio-Rad Laboratories, Inc.
Revvity
Trivitron Healthcare.

Key Growth Drivers:

Rising prevalence of chronic diseases: Increasing cases of non-communicable diseases like diabetes, cardiovascular disorders, and cancer are pushing demand for preventive healthcare services to reduce disease incidence and manage conditions early.

Advancements in medical technology: Innovations such as AI-powered diagnostics, digital health platforms, wearable monitoring devices, and personalized medicine enable early detection, risk assessment, and timely interventions that drive market expansion.

Increasing healthcare costs and focus on value-based care: The high cost of treating chronic diseases and hospitalizations is propelling a shift toward prevention-oriented healthcare models supported by government initiatives, corporate wellness programs, and public health investments aiming to reduce overall healthcare spending.

Segments Covered in the Preventive Healthcare Market:

By Type: Products, Services.

By Application: Vaccination, Health Monitoring/Screening, Condition Management, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=preventive-healthcare-market

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Preventive Healthcare market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Preventive Healthcare Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Preventive Healthcare market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Preventive Healthcare Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Preventive Healthcare Market in 2025?
◆ What is the projected growth rate of the Preventive Healthcare Market through 2033?
◆ Who are the key players in the Preventive Healthcare Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.